Sheng Tai
- Molecular Biology top 5%
- Cancer Research top 2%
- Immunology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 5%
- Co-authors
- Chang Yin LiangAllan TsungHai HuangPatricia LoughranSamer TohmeJiaoti HuangWilliam OhHong Zhang
- Topics
- MicroRNA in disease regulation (16 papers)Cancer-related molecular mechanisms research (16 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers)
- Cited by
- Cancer ResearchImmunologyUrology
- Journals
- PLoS ONEBiomaterialsHepatology
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Sheng Tai
105 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Molecular Biology 1.7k
- Cancer Research 1.0k
- Immunology 786
- Pulmonary and Respiratory Medicine 528
- Oncology 478
Countries citing papers authored by Sheng Tai
This map shows the geographic impact of Sheng Tai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Tai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Tai more than expected).
Fields of papers citing papers by Sheng Tai
This network shows the impact of papers produced by Sheng Tai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Tai. The network helps show where Sheng Tai may publish in the future.
Co-authorship network of co-authors of Sheng Tai
This figure shows the co-authorship network connecting the top 25 collaborators of Sheng Tai. A scholar is included among the top collaborators of Sheng Tai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng Tai. Sheng Tai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 0 | |
| 7 | 2 | |
| 8 | 5 | |
| 9 | 14 | |
| 10 | 39 | |
| 11 | 1 | |
| 12 | 13 | |
| 13 | 28 | |
| 14 | 213 | |
| 15 | 27 | |
| 16 | 1 | |
| 17 | 24 | |
| 18 | 24 | |
| 19 | 23 | |
| 20 | 23 |
About Sheng Tai
Sheng Tai is a scholar working on Cancer Research, Urology and Pulmonary and Respiratory Medicine, having authored 110 papers that have together received 3.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (16 papers), Cancer-related molecular mechanisms research (16 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers). The work is most often cited by research in Cancer Research (1.0k citations), Immunology (786 citations) and Urology (215 citations). Sheng Tai has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Chang Yin Liang, Allan Tsung, Hai Huang, Patricia Loughran, Samer Tohme, Jiaoti Huang, William Oh, Hong Zhang, Yin Sun and Jill Squires. Their work appears in journals such as PLoS ONE, Biomaterials and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.